A novel model of portal vein transplantation in mice using two-cuff technique.
Sheng Yan,Qiyi Zhang,Minxia Cai,Da Yu,Jie Chen,Pengfei Yu,Qiyu Zhao,Lin Zhou,Matthias Hoffmann,Shusen Zheng
DOI: https://doi.org/10.1002/micr.20404
2007-01-01
Microsurgery
Abstract:Allogeneic portal vein (PV) grafts have been widely used for vascular reconstruction in the aggressive biliary-pancreatic surgery and partial liver transplantation. We developed a novel PV transplantation model aimed at studying the pathologic alteration of the grafts and further managements. The PV graft was implanted orthotopically into the recipient using two-cuff technique. A total of 80 PV transplants have been performed, and the overall survival rate for the recipients was 91.3% (73/80). Mice were randomly separated into isografts group, allografts group, and allografts group treated with CTLA4-lg. PV grafts were harvested on the 1st, 2nd, 4th, and 8th postoperative week. The isografts remained intact vascular structure, and the allografts developed marked, retection with significant increase in wall thickness (95 +/- 19 mu m vs. 49 +/- 7 pm; P < 0.01) and decrease in lumen area (1.9 +/- 1.1 X 10(4) m vs. 7.7 +/- 3.1 X 10(4) mu m(2); P < 0.01) on the 4th week. In the CTLA4-Ig treated group, the vascular thickness and lumen area were significantly i roved when compared with the 7tM2 VS. 1.9 +/- 1.1 X 10(4) mu m(2), P untreated allografts (wall-thickness: 53 +/- mu m vs. 95 +/- 19 mu m, P < 0.01; lumen area: 8.8 +/- 2.4 X 10(4) mu m(2) 1.9 +/- 1.1 X 10(4) mu m(2) P < 0.01) on the 4th week. In conclusion, the PV transplantation model in mice using two-cuff technique is a feasible procedure with a high survival rate. The PV allografts responded well to the CTLA4-Ig therapy in our preliminary research by the model. (c) 2007 Wiley-Liss, Inc.